The Cigna Group has entered into a strategic partnership with OpenAI to integrate advanced AI in clinical workflows, with an initial focus on enhancing cancer care. Announced on September 23, the collaboration will build OpenAI’s tools into the operational workflows of Cigna Healthcare and Accredo Specialty Pharmacy. The primary capability introduced through this deal will provide oncology nurses and case managers with an AI-enabled interface that synthesizes clinical, pharmacy, behavioral, and benefits data for individual members. This consolidated view is intended to help specialized clinicians identify patient needs earlier and offer personalized support during the critical periods between physician visits.
The system is designed to address the challenges patients face between appointments, such as managing treatment side effects, addressing new symptoms, and answering complex questions about their diagnosis. By feeding insights from member responses back into the system, the partnership aims to refine future guidance and improve clinical outcomes over time. According to Amy Flaster, MD, Cigna’s chief medical officer, bringing the power of OpenAI to the group will better connect patients to specialized resources and support, whether they are dealing with the physical impact of treatment or the emotional burden of a diagnosis.
Expansion of Cigna’s Digital Health Infrastructure
The collaboration with OpenAI follows other significant artificial intelligence initiatives already established by The Cigna Group. In July, the company launched Pharmacy Forward, a $100 million AI-driven program under Accredo, designed to expand personalized care management within its health plans. The group has reported that these expanded programs have already contributed to a 42% reduction in avoidable hospital stays among engaged members. By further integrating AI in clinical workflows, Cigna seeks to continue this trend of improving healthcare efficiency through data-driven insights.
This partnership adds Cigna to a growing list of major health insurers collaborating with artificial intelligence firms to modernize their operations. Other recent industry moves include Optum’s partnership with Anthropic in July and Elevance Health’s 2023 agreement with OpenAI to provide enterprise ChatGPT access and training to its workforce. The deal reflects a broader industry shift toward utilizing generative AI to synthesize complex healthcare information and provide more timely, personalized intervention for members managing chronic or complex conditions.